Myasthenia gravis: the role of complement at the neuromuscular junction von Howard, James F.

Volltext

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic von Jacob, Saiju, Muppidi, Srikanth, Guidon, Amanda, Guptill, Jeffrey, Hehir, Michael, Howard, James F., Illa, Isabel, Mantegazza, Renato, Murai, Hiroyuki, Utsugisawa, Kimiaki, Vissing, John, Wiendl, Heinz, Nowak, Richard J.

Volltext

Complement Inhibitor Therapy for Myasthenia Gravis von Albazli, Khaled, Kaminski, Henry J., Howard, Jr James F.

Volltext

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase... von Granit, Volkan, Benatar, Michael, Kurtoglu, Metin, Miljković, Miloš D, Chahin, Nizar, Sahagian, Gregory, Feinberg, Marc H, Slansky, Adam, Vu, Tuan, Jewell, Christopher M, Singer, Michael S, Kalayoglu, Murat V, Howard, James F, Mozaffar, Tahseen, Granit, Volkan, Benatar, Michael, Mozaffar, Tahseen, Chahin, Nizar, Howard, James F., Slansky, Adam D., Feinberg, Marc H., Sahagian, Gregory, Vu, Tuan, Pereira, Denise, Steele, Julie, Paredes, Maria Elena, Benjamin, Cara, Komanduri, Krishna, Habib, Ali Aamer, Fong, Julia Kimberly, De La Cruz, Luis, Dimitrova, Diana, Chopra, Manisha, Holley, Kelly, DeMaria, Gabrielle, Tenorio, April, Requena, Naraly, Brooks, Beverly Mackanzie, Suresh, Niraja, Farias, Jerrica, Miljković, Miloš D, Kurtoglu, Metin, Ngo Casi, Minhtran, Chowdhury, Adam, Kamboh, Hafsa, Stewart, C Andrew, Tosun, Mehmet, Shan, Yufei, Daniel, Shaji, Duvernay, Matthew T., Kireeva, Maria, English, Emily, Jewell, Christopher M., Singer, Michael S, Kalayoglu, Murat V

Volltext

A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis von Howard Jr, James F., Barohn, Richard J., Cutter, Gary R., Freimer, Miriam, Juel, Vern C., Mozaffar, Tahseen, Mellion, Michelle L., Benatar, Michael G., Farrugia, Maria Elena, Wang, Jing Jing, Malhotra, Suneil S., Kissel, John T.

Volltext

Improvement of fatigue in generalised myasthenia gravis with zilucoplan von Weiss, Michael D., Freimer, Miriam, Leite, M. Isabel, Maniaol, Angelina, Utsugisawa, Kimiaki, Bloemers, Jos, Boroojerdi, Babak, Howard, Emily, Savic, Natasa, Howard, James F.

Volltext

Time to response with ravulizumab, a long‐acting terminal complement inhibitor, in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis von Habib, Ali A., Benatar, Michael, Vu, Tuan, Meisel, Andreas, Attarian, Shahram, Katsuno, Masahisa, Liao, Serena, Beasley, Kathleen N., Howard, James F.

Volltext

Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study von Howard, James F., Vu, Tuan, Mantegazza, Renato, Kushlaf, Hani, Suzuki, Shigeaki, Wiendl, Heinz, Beasley, Kathleen N., Liao, Serena, Meisel, Andreas

Volltext

Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-l... von Meisel, Andreas, Annane, Djillali, Vu, Tuan, Mantegazza, Renato, Katsuno, Masahisa, Aguzzi, Rasha, Frick, Glen, Gault, Laura, Howard, James F.

Volltext

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) von Muppidi, Srikanth, Guptill, Jeffrey T, Jacob, Saiju, Li, Yingkai, Farrugia, Maria E, Guidon, Amanda C, Tavee, Jinny O, Kaminski, Henry, Howard, James F, Cutter, Gary, Wiendl, Heinz, Maas, Matthew B, Illa, Isabel, Mantegazza, Renato, Murai, Hiroyuki, Utsugisawa, Kimiaki, Nowak, Richard J, Guidon, Amanda C, Tyagi, Alok, Sousa, Ana Paula, Amato, Anthony A, Pinto, Ashwin, Roy, Bhaskar, Carmichael, Caroline, Dodig, Dubravka, Burke, Georgina, Cutter, Gary R, Kaminski, Henry J, Wiendl, Heinz, Murai, Hiroyuki, Lee, Ikjae, Illa, Isabel, Guptill, Jeffrey, Howard, James F., Caress, James, Pritchard, Jane, Tavee, Jinny O, Vissing, John, Best, Kamla, Utsugisawa, Kimiaki, Ramezani, Mahtab, Maas, Mathew, Farrugia, Maria E, Hehir, Michael K, Kaku, Michelle, Esquivel, Natalia Jiménez, Gallagher, Paul, Maddison, Paul, Ambrose, Philip A, Mantegazza, Renato E, Nowak, Richard J, Do Campo, Rocio Vazquez, Jacob, Saiju, Saba, Sami, Nafissi, Shahriar, Itoyama, Shannon, Muppidi, Srikanth, Viegas, Stuart Viegas, Marshall, Victoria, Li, Yingkai Li

Volltext

Clinical features of LRP4/agrin‐antibody–positive myasthenia gravis: A multicenter study von Rivner, Michael H., Quarles, Brandy M., Pan, Jin‐Xiu, Yu, Zheng, Howard, James F., Corse, Andrea, Dimachkie, Mazen M., Jackson, Carlayne, Vu, Tuan, Small, George, Lisak, Robert P., Belsh, Jerry, Lee, Ikjae, Nowak, Richard J., Baute, Vanessa, Scelsa, Stephen, Fernandes, J. Americo, Simmons, Zachary, Swenson, Andrea, Barohn, Richard, Sanka, R. Bhavaraju, Gooch, Clifton, Ubogu, Eroboghene, Caress, James, Pasnoor, Mamatha, Xu, Hongyan, Mei, Lin

Volltext

Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis von Vu, Tuan, Meisel, Andreas, Mantegazza, Renato, Annane, Djillali, Katsuno, Masahisa, Aguzzi, Rasha, Enayetallah, Ahmed, Beasley, Kathleen N., Rampal, Nishi, Howard, James F.

Volltext

Schwann cell-derived periostin promotes autoimmune peripheral polyneuropathy via macrophage recruitment von Allard, Denise E, Wang, Yan, Li, Jian Joel, Conley, Bridget, Xu, Erin W, Sailer, David, Kimpston, Caellaigh, Notini, Rebecca, Smith, Collin-Jamal, Koseoglu, Emel, Starmer, Joshua, Zeng, Xiaopei L, Howard, Jr, James F, Hoke, Ahmet, Scherer, Steven S, Su, Maureen A

Volltext

Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study... von Howard, James F., Vu, Tuan, Li, George, Korobko, Denis, Smilowski, Marek, Liu, Li, Gistelinck, Fien, Steeland, Sophie, Noukens, Jan, Van Hoorick, Benjamin, Podhorna, Jana, Borgions, Filip, Li, Yuebing, Utsugisawa, Kimiaki, Wiendl, Heinz, De Bleecker, Jan L., Mantegazza, Renato

Volltext

Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study von Bril, Vera, Howard, James F., Karam, Chafic, De Bleecker, Jan L., Murai, Hiroyuki, Utsugisawa, Kimiaki, Ulrichts, Peter, Brauer, Edward, Zhao, Sihui, Mantegazza, Renato, Vu, Tuan

Volltext

The Relationship between Trans-Lesional Conduction, Motor Neuron Pool Excitability, and Motor Function in Dogs with Incomplete Recovery from Severe Spinal Cord Injury von Lewis, Melissa J, Howard, Jr, James F, Olby, Natasha J

Volltext

Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence von Vu, Tuan, Wiendl, Heinz, Katsuno, Masahisa, Reddel, Stephen W, Howard, Jr, James F

Volltext

Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis von Howard, Jr, James F, Bril, Vera, Vu, Tuan, Karam, Chafic, Peric, Stojan, De Bleecker, Jan L, Murai, Hiroyuki, Meisel, Andreas, Beydoun, Said R, Pasnoor, Mamatha, Guglietta, Antonio, Van Hoorick, Benjamin, Steeland, Sophie, T'joen, Caroline, Utsugisawa, Kimiaki, Verschuuren, Jan, Mantegazza, Renato

Volltext

Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review von Hehir, Michael K, Hobson-Webb, Lisa D, Benatar, Michael, Barnett, Carolina, Silvestri, Nicholas J, Howard, James F, Howard, Diantha, Visser, Amy, Crum, Brian A, Nowak, Richard, Beekman, Rachel, Kumar, Aditya, Ruzhansky, Katherine, Chen, I-Hweii Amy, Pulley, Michael T, LaBoy, Shannon M, Fellman, Melissa A, Greene, Shane M, Pasnoor, Mamatha, Burns, Ted M

Volltext

Post-hoc analyses from the ADAPT clinical study demonstrate aggregate sustained benefit of Efgartigimod in generalized myasthenia gravis von Dewilde, Sarah, Griffiths, Alison, Qi, Cynthia Z., Phillips, Glenn, Gelinas, Deborah, Brauer, Edward, Mantegazza, Renato, Howard, James F.

Volltext